Scopus BioPharma Inc.
SCPS · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $125 | $7,943 | $1,832 | $37 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $1 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $265 | $242 | $140 | $731 |
| Total Curr. Assets | $390 | $8,185 | $1,972 | $768 |
| Property Plant & Equip (Net) | $2 | $3 | $2 | $4 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $2 | $3 | $2 | $4 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $392 | $8,188 | $1,974 | $772 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $0 | $0 |
| Short-Term Debt | $0 | $0 | $2,284 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $7,454 | $4,170 | $1,522 | $855 |
| Total Curr. Liab. | $7,454 | $4,170 | $3,805 | $855 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $2,284 | $0 |
| Other Liabilities | $0 | $0 | -$2,284 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $7,454 | $4,170 | $3,805 | $855 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $21 | $21 | $15 | $13 |
| Retained Earnings | -$53,065 | -$41,455 | -$14,502 | -$3,639 |
| AOCI | -$5 | -$87 | -$68 | -$33 |
| Other Equity | $46,485 | $45,538 | $12,724 | $3,578 |
| Total Equity | -$6,564 | $4,017 | -$1,831 | -$83 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$498 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $392 | $8,188 | $1,974 | $772 |
| Net Debt | -$125 | -$7,943 | $452 | -$37 |